Indication
Hyper IgM Syndrome
1 clinical trial
5 products
1 drug
Clinical trial
Allogeneic Hematopoietic Stem Cell Transplant for Patients With Primary Immune DeficienciesStatus: Recruiting, Estimated PCD: 2025-12-01
Product
AlemtuzumabProduct
CyclophosphamideProduct
BusulfanProduct
Stem Cell TransplantationProduct
Fludarabine phosphateDrug
Melphalan